InhaLac® 70
Premium sieved alpha-lactose monohydrate for DPI applications – Ph.Eur., USP-NF, JP, ChP
MEGGLE’s InhaLac® portfolio offers a broad range of high-purity lactose grades specifically engineered for dry powder inhalation (DPI). With decades of expertise, we deliver consistent particle size distributions, excellent flow properties, and superior batch-to-batch uniformity – ensuring optimal performance in DPI formulations. Whether for originators or generics, MEGGLE is your trusted partner for tailored carrier solutions that meet global pharmacopeial standards.
Sieved lactose monohydrate is a key excipient in dry powder inhalation (DPI) formulations, offering critical advantages that support consistent drug delivery and efficient production processes. Its well-defined and narrow particle size distribution ensures excellent flow properties and reliable dosing. Additionally, the tailored surface characteristics of sieved lactose enhance the interaction with active pharmaceutical ingredients (APIs), improving drug dispersion and lung deposition.
Key benefits of sieved lactose monohydrate in DPI formulations:
These properties make sieved lactose an ideal carrier for both originator and generic DPI products, supporting robust formulation performance and patient-centric drug delivery.
Milled lactose monohydrate is a critical excipient in dry powder inhalation (DPI) formulations, valued for its tailored particle size distribution and unique surface morphology. Its irregularly shaped particles contribute to improved powder flow and enhance the interaction with active pharmaceutical ingredients (APIs). These properties support efficient aerosolization and consistent delivery of medication to the lungs. Milled lactose is especially useful in customizing DPI formulations, either as a stand-alone carrier or in combination with other lactose grades.
Key benefits of milled lactose monohydrate in DPI formulations:
These characteristics make milled lactose monohydrate a versatile and reliable choice for high-performance DPI formulations, supporting both formulation stability and patient-centric drug delivery.
Fine milled and micronized lactose monohydrate are specialized carrier grades used in dry powder inhalation (DPI) formulations to optimize drug delivery performance. Fine milled lactose offers a narrow particle size distribution and favorable flow properties, making it suitable for use as a primary or co-carrier in DPI systems. Micronized lactose, with its significantly smaller particle size, is typically used in ternary blends to improve the aerodynamic behavior of the formulation. By occupying high-energy binding sites on the surface of coarser carriers, micronized lactose facilitates better detachment of the active pharmaceutical ingredient (API), increasing the fine particle fraction (FPF) that reaches the lungs.
Key benefits of fine milled and micronized lactose monohydrate in DPI formulations:
These characteristics make fine milled and micronized lactose valuable tools for tailoring DPI formulations to specific device types and therapeutic requirements.